eli lilly glp-1 news Big from Lilly: they’ve just released new topline findings for orforglipron, their oral candidate. Another exciting step forward in the evolving landscape of obesity and diabetes care., Lilly's new GLP-1 pill is

Regulation of feed intake, growth, nutrient and energy utilisation in European sea bass (Dicentrarchus labrax) fed high fat diets

Liver Health: GLP-1 agonists can improve liver health, particularly concerning fatty liver disease

In contrast, in behavioural programmes where people havent had the extra assistance of drugs, they probably have to practice those strategies more, and maybe they therefore are more persistent over time. She said its very clear that some type of treatment, some sort of intervention, needs to continue if the benefits of drugs for obesity are to last long-term

Whole fish protein was measured by Kjeltec TM 8200 (FOSS, Sweden)

Byetta (exenatide immediate-release) Summary of Product Characteristics